Shopping Cart 0
Cart Subtotal
AED 0

ValiRx Plc (VAL) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753

Details

Summary

ValiRx Plc (ValiRx) is a life science company that develops therapeutics for the treatment of clinical stage cancer. The company's products include VAL201-prostate cancer, VAL401-lung cancer, GeneICE-BCL-2, and NAV3 cancer screening test. It uses GeneICE technology, which enables silencing of specific genes by targeted histone deacetylation for chromatin condensation. ValiRx's ValiMedix division sells and distributes oncology therapeutics. The company's ValiPharma division is a therapeutics division that provides technologies for the treatment of cancer. Its's ValiFinn division offers research and development services. The company also develops clinical trials, which is used to treat hormone induced refractory prostate cancer and other conditions of hormone. ValiRx is headquartered in London, the UK.

ValiRx Plc (VAL)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

ValiRx Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

ValiRx Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

ValiRx Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

ValiRx Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

ValiRx Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

ValiRx Plc, Medical Equipment, Deal Details 10

Asset Purchase 10

ValiRx Acquires Biomarkers Business Unit From Pharmatest Services For USD 0.2 Million 10

Equity Offering 12

ValiRx Raises USD1.5 Million in Private Placement of Shares 12

ValiRx Raises USD1.33 Million in Private Placement of Shares 13

ValiRx Raises USD0.05 Million in Private Placement of Shares up on Exercise of Warrants 14

ValiRx Raises USD0.1 Million in Private Placement of Shares up on Exercise of Warrants 15

ValiRx Raises USD0.7 Million in Private Placement of Shares 16

Valirx Raises Funds in Private Placement of Shares 17

Valirx Raises USD1.4 Million in Private Placement of Shares 18

Valirx Raises USD1.58 Million in Placing of Ordinary Shares 19

Acquisition 20

ValiRx Divests Its Stake In VolitionRx For USD 0.6 Million 20

ValiRx Plc-Key Competitors 21

ValiRx Plc-Key Employees 22

ValiRx Plc-Locations And Subsidiaries 23

Head Office 23

Other Locations & Subsidiaries 23

Joint Venture 23

Recent Developments 24

Financial Announcements 24

Sep 25, 2018: VALIRX: Half yearly report for the period ended 30 June 2018 24

Apr 10, 2018: ValiRx: Final Results for the Year Ended 31 December 2017 26

Sep 26, 2017: Valirx: Half Yearly Report For The Period Ended 30 June 2017 30

May 05, 2017: ValiRx: Final Results for the Year Ended 31 December 2016 32

Legal and Regulatory 35

Apr 18, 2017: ValiRx: Change of Registered Office 35

Appendix 36

Methodology 36

About GlobalData 36

Contact Us 36

Disclaimer 36


List Of Figure

List of Figures

ValiRx Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

ValiRx Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

ValiRx Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

ValiRx Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

ValiRx Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

ValiRx Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

ValiRx Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

ValiRx Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

ValiRx Plc, Medical Equipment, Key Facts, 2017 2

ValiRx Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

ValiRx Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

ValiRx Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

ValiRx Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

ValiRx Plc, Deals By Market, 2012 to YTD 2018 8

ValiRx Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

ValiRx Acquires Biomarkers Business Unit From Pharmatest Services For USD 0.2 Million 10

ValiRx Raises USD1.5 Million in Private Placement of Shares 12

ValiRx Raises USD1.33 Million in Private Placement of Shares 13

ValiRx Raises USD0.05 Million in Private Placement of Shares up on Exercise of Warrants 14

ValiRx Raises USD0.1 Million in Private Placement of Shares up on Exercise of Warrants 15

ValiRx Raises USD0.7 Million in Private Placement of Shares 16

Valirx Raises Funds in Private Placement of Shares 17

Valirx Raises USD1.4 Million in Private Placement of Shares 18

Valirx Raises USD1.58 Million in Placing of Ordinary Shares 19

ValiRx Divests Its Stake In VolitionRx For USD 0.6 Million 20

ValiRx Plc, Key Competitors 21

ValiRx Plc, Key Employees 22

ValiRx Plc, Subsidiaries 23

ValiRx Plc, Joint Venture 23

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

ValiRx Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

ValiRx Plc (ValiRx) is a life science company that develops therapeutics for the treatment of clinical stage cancer. The company's products include VAL201-prostate cancer, VAL401-lung cancer, GeneICE-BCL-2, and NAV3 cancer screening test. It uses GeneICE technology, which enables silencing of specific genes by targeted histone deacetylation for chromatin condensation. ValiRx's ValiMedix division sells and distributes oncology therapeutics. The company's ValiPharma division is a therapeutics division that provides technologies for the treatment of cancer. Its's ValiFinn division offers research and development services. The company also develops clinical trials, which is used to treat hormone induced refractory prostate cancer and other conditions of hormone. ValiRx is headquartered in London, the UK.

ValiRx Plc (VAL)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

ValiRx Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

ValiRx Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

ValiRx Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

ValiRx Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

ValiRx Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

ValiRx Plc, Medical Equipment, Deal Details 10

Asset Purchase 10

ValiRx Acquires Biomarkers Business Unit From Pharmatest Services For USD 0.2 Million 10

Equity Offering 12

ValiRx Raises USD1.5 Million in Private Placement of Shares 12

ValiRx Raises USD1.33 Million in Private Placement of Shares 13

ValiRx Raises USD0.05 Million in Private Placement of Shares up on Exercise of Warrants 14

ValiRx Raises USD0.1 Million in Private Placement of Shares up on Exercise of Warrants 15

ValiRx Raises USD0.7 Million in Private Placement of Shares 16

Valirx Raises Funds in Private Placement of Shares 17

Valirx Raises USD1.4 Million in Private Placement of Shares 18

Valirx Raises USD1.58 Million in Placing of Ordinary Shares 19

Acquisition 20

ValiRx Divests Its Stake In VolitionRx For USD 0.6 Million 20

ValiRx Plc-Key Competitors 21

ValiRx Plc-Key Employees 22

ValiRx Plc-Locations And Subsidiaries 23

Head Office 23

Other Locations & Subsidiaries 23

Joint Venture 23

Recent Developments 24

Financial Announcements 24

Sep 25, 2018: VALIRX: Half yearly report for the period ended 30 June 2018 24

Apr 10, 2018: ValiRx: Final Results for the Year Ended 31 December 2017 26

Sep 26, 2017: Valirx: Half Yearly Report For The Period Ended 30 June 2017 30

May 05, 2017: ValiRx: Final Results for the Year Ended 31 December 2016 32

Legal and Regulatory 35

Apr 18, 2017: ValiRx: Change of Registered Office 35

Appendix 36

Methodology 36

About GlobalData 36

Contact Us 36

Disclaimer 36


List Of Figure

List of Figures

ValiRx Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

ValiRx Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

ValiRx Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

ValiRx Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

ValiRx Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

ValiRx Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

ValiRx Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

ValiRx Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

ValiRx Plc, Medical Equipment, Key Facts, 2017 2

ValiRx Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

ValiRx Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

ValiRx Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

ValiRx Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

ValiRx Plc, Deals By Market, 2012 to YTD 2018 8

ValiRx Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

ValiRx Acquires Biomarkers Business Unit From Pharmatest Services For USD 0.2 Million 10

ValiRx Raises USD1.5 Million in Private Placement of Shares 12

ValiRx Raises USD1.33 Million in Private Placement of Shares 13

ValiRx Raises USD0.05 Million in Private Placement of Shares up on Exercise of Warrants 14

ValiRx Raises USD0.1 Million in Private Placement of Shares up on Exercise of Warrants 15

ValiRx Raises USD0.7 Million in Private Placement of Shares 16

Valirx Raises Funds in Private Placement of Shares 17

Valirx Raises USD1.4 Million in Private Placement of Shares 18

Valirx Raises USD1.58 Million in Placing of Ordinary Shares 19

ValiRx Divests Its Stake In VolitionRx For USD 0.6 Million 20

ValiRx Plc, Key Competitors 21

ValiRx Plc, Key Employees 22

ValiRx Plc, Subsidiaries 23

ValiRx Plc, Joint Venture 23

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

ValiRx Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.